Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Milanovich, Samuel J.

Sanford Research/Usd
United States

Sanford Community Cancer Program of the North Central Plains (NCORP) 3UG1CA189825-11S1 Vanessa A. White, M.P.H.
Milbury, Kathrin

University Of Tx Md Anderson Can Ctr
United States

Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers 4R37CA231522-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Milbury, Kathrin

University Of Tx Md Anderson Can Ctr
United States

Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers 4R37CA231522-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Milbury, Kathrin

University Of Tx Md Anderson Can Ctr
United States

Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers 4R37CA231522-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Miyano, Masaru

Beckman Research Institute/City Of Hope
United States

Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials 1R03CA300614-01 Sidney Fu, M.D.
Morilak, David A

University Of Texas Hlth Science Center
United States

Therapy-induced cognitive impairment in a rat model of prostate cancer 5R01CA285183-03 John Clifford, Ph.D.
Morilak, David A

University Of Texas Hlth Science Center
United States

Therapy-induced cognitive impairment in a rat model of prostate cancer 5R01CA285183-03 John Clifford, Ph.D.
Morin, Olivier

University Of California, San Francisco
United States

Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity 1R01CA292043-01A1 Marjorie Perloff, M.D.
Morin, Olivier

University Of California, San Francisco
United States

Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity 1R01CA292043-01A1 Marjorie Perloff, M.D.
Moscicki, Anna-Barbara

University Of California Los Angeles
United States

Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies 5R01CA281293-03 Maria Silvina Frech, Ph.D., M.S.
Moses, John Edward

Cold Spring Harbor Laboratory
United States

Discovery of Natural Products and Natural Product Derivatives as Inhibitors of KLK6 to Prevent the Progression of Preneoplastic Ductal Pancreatic Cancer 1UG3CA290364-01A1 Altaf Mohammed, Ph.D.
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Mosher, Catherine E

Indiana University Indianapolis
United States

Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer 5R01CA289486-02
Mu, Ping

Yale University
United States

Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation 5R01CA292949-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.